AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse

CNBC Crypto ▼ very negative

Story

A late-stage clinical trial failed to miss its primary endpoint, U.K.'s laregst drugmaker said Thursday.

Market at publication: BTC $64,027 · ETH $1,776 · Fear & Greed 23

Read at CNBC Crypto

← All crypto news · Search the archive